<DOC>
	<DOCNO>NCT02454647</DOCNO>
	<brief_summary>The aim study evaluate efficacy neoadjuvant approach patient locally advanced gastric cancer identification prognostic factor .</brief_summary>
	<brief_title>Induction Chemotherapy , Chemoradiotherapy Surgery Locally Advanced Gastric Cancer Patients</brief_title>
	<detailed_description>Patients locally advanced gastric cancer ( T3-4 and/or N+ ) include . Initially , patient diagnose computerized tomography scan endoscopic ultrasound . The neoadjuvant strategy consist 3-4 cycle induction chemotherapy follow concurrent chemoradiotherapy . Chemoradiotherapy comprise weekly chemotherapy concurrently daily external beam radiotherapy 45 Gy ) . Surgery schedule 4 6 week end CRT . Pathological response grade accord Becker criterion . Statistical analysis perform IBM SPSS v20 . Estimate whether R0 resection rate , pathological response degree , pattern recurrence long-term outcome may initially predict dynamic prognostic factor tumor size , neutrophil lymphocyte ratio ( NLR ) platelet lymphocyte ratio ( PLR )</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Gastrointestinal Neoplasms</mesh_term>
	<mesh_term>Digestive System Neoplasms</mesh_term>
	<criteria>Histologically confirm adenocarcinoma stomach Age ≥18 year old Performance Status Eastern Cooperative Oncology Group ( ECOG ) 01 Body mass index ≥ 18 No prior chemotherapy chemoradiotherapy TNM stage T3T4 and/or positive regional lymph node ( N+ ) endoscopic ultrasound compute tomography ( CT ) No evidence metastasis ( M0 ) Adequate hematological , liver renal function ( ALT AST≤2.5 UNL , total bilirubin ≤1.5 UNL , serum creatinine ≤1.5 UNL ) Patients previous ( less 10 year ) current history malignant neoplasm , except curatively treated Patients evidence severe uncontrolled systemic disease Medically unfit chemotherapy Tumors involve esophageal junction , comprise siewert I III</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Radiotherapy</keyword>
	<keyword>Neoadjuvant therapy</keyword>
	<keyword>Induction chemotherapy</keyword>
	<keyword>Concurrent chemoradiotherapy</keyword>
	<keyword>Preoperative factor</keyword>
	<keyword>Dynamic factor</keyword>
	<keyword>Prognostic Factor</keyword>
</DOC>